Skip to content

Probiotics assisted eradication treatment of Helicobacter pylori infection in female patients and prevention and treatment of vaginitis complications

Probiotics assisted eradication treatment of Helicobacter pylori infection in female patients and prevention and treatment of vaginitis complications

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054030
Enrollment
Unknown
Registered
2021-12-07
Start date
2021-12-07
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

group A :Probiotics
Group B:standard quadruple therapy

Sponsors

Nanchang First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Women of reproductive age who are sexually active and pre-menopausal, 18 to 50 years of age, within 14 days before menstruation; 2.Voluntarily cooperate and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Diagnosed as malignant ulcer complicated with pyloric obstruction, bleeding and perforation; 2. Associated with vaginal infectious disease or malignant tumor within the past 1 month; 3. Patients with severe underlying diseases such as coronary heart disease, liver disease, and kidney disease; 4. Those who have taken proton pump inhibitors or H2 receptor blockers, bismuth and antibiotics before 4 weeks; 5. Those taking non-steroidal anti-inflammatory drugs or alcoholism at the same time; 6. Patients with other gastric diseases; patients with malignant tumors, immune, blood system and infectious diseases; 7. Those who are allergic to probiotics or cannot take it orally; 8. Women during menstruation, pregnancy and lactation; 9. Patients who are taking oral contraceptives with high estrogen content and oophorectomy patients.

Design outcomes

Primary

MeasureTime frame
Vaginal symptoms;

Secondary

MeasureTime frame
Helicobacter pylori eradication rate;Intestinal microenvironment;Vaginal microenvironment;

Countries

China

Contacts

Public ContactFang Nian

Nanchang First Hospital

fnian3893@126.com+86 139 7005 3893

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026